The network pharmacology analysis, as shown in Figure 1B,C, highlights key genes or proteins associated with cancer, including SRC, STAT3, PIK3CA, MAPK (ERK2), EGFR, JAK1, ERBB2 (HER2), MTOR, BRAF, and ALK, as listed in Table 3. This evidence concerns the gene MTOR and cancer.